You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -4.5 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 0.0 |
Price / Book value | 3.9 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2017-12-31 | n/a | -3.21 | -8.37p | -17.0 | 0.0 | n/a | n/a | 0.0% |
2018-12-31 | n/a | -6.01 | -11.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | n/a | -5.52 | -10.66p | -4.0 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | n/a | -6.48 | -12.00p | -5.7 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -6.27 | -8.90p | -11.8 | 0.0 | n/a | n/a | 0.0% |
Destiny Pharma awarded Cystic Fibrosis Foundation project Sharecast News | 12 Jul |
---|---|
Destiny Pharma appoints Yuri Martina as chief medical officer Sharecast News | 03 May |
Destiny Pharma to raise up to £7m in discounted fundraising Sharecast News | 08 Mar |
Chair’s Investor Update | 28-Jul-22 07:00 |
---|---|
Publication of new data on NTCD-M3 | 26-Jul-22 07:00 |
Positive update from US FDA on XF-73 Phase 3 | 19-Jul-22 07:00 |
Grant from the Cystic Fibrosis Foundation | 12-Jul-22 07:00 |
Publication of XF-73 drug synergy data | 07-Jul-22 07:00 |